This is a paid advertisement for legal services. Sponsor and responsible law firm: JAG Legal Group, using the 1-800-LAW-FIRM brand.

Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death. Consult your physician before making any decision regarding prescribed medication or medical treatment.

Gabapentin and pregabalin remain FDA-approved for their approved indications. This advertisement is not an FDA notice or a product recall. Research findings do not establish that a medicine caused an individual injury. Jurisdiction and representation disclosures.

LEGAL INFORMATION FOR PATIENTS & FAMILIES Attorney advertising · JAG Legal Group
RESEARCH & SAFETY

A Philadelphia gabapentinoid complaint: allegations, dates and limits

A September 25 complaint discussed in November names gabapentin and pregabalin. It is an allegation, not a ruling that either medicine caused dementia.

JAG Legal Group · Published November 16, 2026

Published November 16, 2026 · Complaint filed September 25, 2026 · News report published November 10, 2026

The filing predates the headline

A November 10 report drew attention to Crystal Seifers v. Pfizer Inc. et al. The court-stamped complaint, available as a PDF copy hosted by AboutLawsuits, identifies Philadelphia Court of Common Pleas case 260903316 and a September 25, 2026 filing date. This is coverage of an earlier filing, not a lawsuit first filed in November.

What the complaint alleges

The complaint names Pfizer, Greenstone, Pharmacia & Upjohn, Pharmacia and Viatris. It alleges that inadequate warnings accompanied gabapentinoid treatment and that the plaintiff experienced neurocognitive injuries. Its medication table lists gabapentin and pregabalin prescriptions. These are allegations by the plaintiff; the complaint is not a court finding of causation or liability.

Two medicines require two histories

Gabapentin, including Neurontin, and pregabalin, including Lyrica, are different medicines. A history involving both does not identify the effects of either one in isolation. Our research guide explains why observational associations do not prove causation. For your own review, ask the pharmacy for a fill-by-fill history showing the active ingredient, brand or generic name, manufacturer and dates. A defendant named in someone else's complaint is not automatically responsible for your medicine.

What a complaint does not decide

This document does not establish a settlement fund, a nationwide filing cutoff, or eligibility for other patients. Nor does it verify the rules or current status of a coordinated state program. Our federal MDL report guide addresses a separate source and its limits.

Preparing for an individual review

Keep first and last use dates, symptom and diagnosis dates, prescribing records and the locations of treatment. A family member helping with records may need the patient's permission or legal authority. JAG Legal Group must assess the product history, medical evidence, applicable jurisdiction and deadlines individually. Contacting the firm does not file a claim or pause a deadline. See our records checklist and legal-options guide. Do not change prescribed treatment because of a lawsuit headline.

YOUR NEXT STEP

You don’t have to sort
through this alone.

Talk through your concerns and learn what information a legal review may require.

Call 1-800-LAW-FIRM ↗

1-800-529-3476 · No obligation to retain a lawyer

Request a reviewCall 1-800-LAW-FIRM ↗